ClinicalTrials.gov
History of Changes for Study: NCT04754594
To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older
Latest version (submitted October 25, 2023) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 February 11, 2021 None (earliest Version on record)
2 March 5, 2021 Recruitment Status, Study Status, Eligibility, Contacts/Locations and Oversight
3 March 30, 2021 Contacts/Locations and Study Status
4 April 9, 2021 Contacts/Locations, Study Status, Eligibility and Outcome Measures
5 May 17, 2021 Study Status and Contacts/Locations
6 May 27, 2021 Contacts/Locations, Study Status and Study Design
7 June 16, 2021 Contacts/Locations, Outcome Measures, Study Description, Study Status and Study Design
8 July 19, 2021 Contacts/Locations, Study Status and Study Design
9 August 16, 2021 Contacts/Locations and Study Status
10 September 13, 2021 Contacts/Locations, Study Status and Study Design
11 September 29, 2021 Contacts/Locations and Study Status
12 October 27, 2021 Contacts/Locations and Study Status
13 November 16, 2021 Recruitment Status, Contacts/Locations, Study Status and Study Design
14 December 17, 2021 Contacts/Locations, Study Status and Study Design
15 January 31, 2022 Contacts/Locations, Study Status and Study Design
16 February 17, 2022 IPDSharing and Study Status
17 May 15, 2022 Contacts/Locations, Study Status, Outcome Measures, Study Design and Study Description
18 August 3, 2022 Study Status, Contacts/Locations, Outcome Measures, Conditions and Study Identification
19 August 22, 2022 Recruitment Status, Study Status, Contacts/Locations and Study Design
20 July 12, 2023 Eligibility, Contacts/Locations, Study Design, Study Status and Study Description
21 July 14, 2023
Quality Control Review has not concluded Returned: August 4, 2023
Outcome Measures, Contacts/Locations, Study Status, Study Design, Document Section
22 August 30, 2023
Quality Control Review has not concluded Returned: September 22, 2023
Adverse Events, Outcome Measures, Study Status, Participant Flow and Study Design
23 October 25, 2023
Quality Control Review has not concluded Returned: November 13, 2023
Study Status, Participant Flow and Study Design
Comparison Format:
U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services